Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of adjuvanted hepatitis B surface antigen vaccine versus Engerix-B in healthy HBV-naive adults
2012-001344-22Phase 2Terminated
- Sponsor
- GSK
- Start
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2231392A, Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Started Jan 2013; status: terminated.
02
Drugs
GSK2231392AHepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2012-001344-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001344-22.